| scholarly article | Q13442814 |
| P50 | author | Jerome de Seze | Q55233961 |
| Hervé Drobecq | Q55704495 | ||
| Lionel Almeras | Q56417471 | ||
| Sylvain Dubucquoi | Q56807887 | ||
| P2093 | author name string | Patrick Vermersch | |
| Didier Lefranc | |||
| Lionel Prin | |||
| P433 | issue | 7 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 2184-2194 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Proteomics | Q15614164 |
| P1476 | title | New antigenic candidates in multiple sclerosis: identification by serological proteome analysis | |
| P478 | volume | 4 |
| Q33368998 | Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis |
| Q34847941 | Altered protein networks and cellular pathways in severe west nile disease in mice. |
| Q35680148 | An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies |
| Q39482700 | An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome |
| Q33812214 | Analysis of the mitochondrial proteome in multiple sclerosis cortex |
| Q64120727 | Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA) |
| Q37160963 | Autoantibody profiling in multiple sclerosis using arrays of human protein fragments |
| Q35994386 | Biological markers in CSF and blood for axonal degeneration in multiple sclerosis |
| Q37755142 | Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity |
| Q35664136 | Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria. |
| Q94103027 | Current Awareness on Comparative and Functional Genomics |
| Q57719377 | Evaluation of new immunological targets in neuromyelitis optica |
| Q34835462 | Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach |
| Q47925417 | Immunoproteomic identification of antigenic salivary biomarkers detected by Ixodes ricinus-exposed rabbit sera |
| Q59133606 | No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients |
| Q47985196 | Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins |
| Q33934205 | Plasmodium falciparum proteome changes in response to doxycycline treatment |
| Q34185195 | Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders |
| Q34110724 | Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts |
| Q40601989 | Serological proteome analysis reveals new specific biases in the IgM and IgG autoantibody repertoires in autoimmune polyendocrine syndrome type 1. |
| Q48237116 | Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort |
| Q48017215 | Singular, systemic, self-reactive IgG patterns related to age: relationship with cerebral malaria susceptibility in exposed subjects residing in an endemic area in Abidjan, Côte-d'Ivoire |
| Q34221892 | Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria |
| Q38171465 | Ten years of proteomics in multiple sclerosis |
| Q52722816 | The role of septin 7 in physiology and pathological disease: A systematic review of current status. |
| Q38552059 | Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform. |
Search more.